The Journal of Clinical Pharmacology

Cover image for The Journal of Clinical Pharmacology

July 2006

Volume 46, Issue 7

Pages 714–816

  1. Editorial

    1. Top of page
    2. Editorial
    3. Drug Interactions
    4. Clinical Studies
    1. Updates for The Journal of Clinical Pharmacology (page 714)

      Lisa L. Le Moltke

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/0091270006290856

    1. Pharmacokinetics and Safety Profile of Ispronicline (TC-1734), a New Brain Nicotinic Receptor Partial Agonist, in Young Healthy Male Volunteers (pages 715–736)

      G. Dunbar, A. Demazières, A. Monreal, C. Cisterni, D. Metzger, R. Kuchibhatla and R. Luthringer

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/0091270006288730

    2. Pharmacokinetics and Urinary Excretion of Vincristine Sulfate Liposomes Injection in Metastatic Melanoma Patients (pages 727–737)

      Dr Agop Y. Bedikian, Ms Anna Vardeleon, Ms Teresa Smith, Ms Susan Campbell and Dr Rostam Namdari

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/0091270006288953

    3. Pharmacokinetic/Pharmacodynamic Modeling of Pegfilgrastim in Healthy Subjects (pages 747–757)

      Lorin K. Roskos, Peggy Lum, Pamela Lockbaum, Gisela Schwab and Bing-Bing Yang

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/0091270006288731

  2. Drug Interactions

    1. Top of page
    2. Editorial
    3. Drug Interactions
    4. Clinical Studies
    1. Time-Dependent Interaction Between Lopinavir/Ritonavir and Fexofenadine (pages 758–767)

      P. G. Rolf, Dr van Heeswijk, Mr Marc Bourbeau, Ms Pearl Campbell, Ms Isabelle Seguin, Mr Bobby M. Chauhan, Dr Brian C. Foster and Dr D. William Cameron

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/0091270006288733

    1. Drug-Drug Interaction After Single Oral Doses of the Furanocoumarin Methoxsalen and Cyclosporine (pages 768–775)

      Dr Malie Rheeders, Ms Marlène Bouwer and Dr Theunis C. Goosen

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/0091270006288732

    2. Study of the Pharmacokinetic Interaction Between Simvastatin and Prescription Omega-3-Acid Ethyl Esters (pages 785–796)

      Dr J. M. McKenney, Dr D. Swearingen, Mr M. Di Spirito, Mr R. Doyle, Ms C. Pantaleon, Mr D. Kling and Dr R. A. Shalwitz

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/0091270006289849

    3. Lack of Effect of Aprepitant on Hydrodolasetron Pharmacokinetics in CYP2D6 Extensive and Poor Metabolizers (pages 792–801)

      Dr Susie Xiujiang Li, Mr Edward Pequignot, Ms Deborah Panebianco, Dr Paul Lupinacci, Dr Anup Majumdar, Dr Laura Rosen, Ms Tuli Ahmed, Dr Jane E. Royalty, Dr Thomas H. Rushmore, Dr M. Gail Murphy and Dr Kevin J. Petty

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/0091270006288954

    4. Discordance Between N-acetyltransferase 2 Phenotype and Genotype in a Population of Hmong Subjects (pages 802–811)

      Dr Robert J. Straka, Dr R. Todd Burkhardt, Dr Nicholas P. Lang, Dr Kelly Z. Hadsall and Dr Michael Y. Tsai

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/0091270006288955

  3. Clinical Studies

    1. Top of page
    2. Editorial
    3. Drug Interactions
    4. Clinical Studies
    1. High-Dose Statin Treatment Does Not Alter Plasma Marker for Brain Cholesterol Metabolism in Patients With Moderately Elevated Plasma Cholesterol Levels (pages 812–816)

      Ms Karin M. Thelen, Dr Reijo Laaksonen, Dr Hannu Päivä, Dr Terho Lehtimäki and Dr Dieter Lütjohann

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/0091270006289851

SEARCH

SEARCH BY CITATION